EMBLEM Technology Transfer GmbH has licensed the patented technology to CHO Plus for transfecting cells to produce therapeutic agents ... after transfection, the activity is rapidly cleared.

after transfection, the activity is rapidly cleared. CHO Plus has developed patented cell engineering technology that increases the capacity of cells to produce therapeutic proteins, and viral ...

EMBLEM Technology Transfer GmbH has licensed the patented technology to CHO Plus for transfecting cells to produce therapeutic agents.

About CHO Plus, Inc. CHO Plus, a privately held company located in South San Francisco, was founded with the mission of increasing the productivity of cells used for manufacturing life-saving ...

The penis is easily accessible, with an easily-compressible blood supply to enhance the uptake of injectable transfection agents and prevent spread to surrounding organs. Furthermore, the low ...

Creative Biolabs Modifying exosome surfaces and precision cargo loading technologies enhance targeted delivery, which advances disease trea ...

For transfection with Tet2 plasmids or siRNA, FuGENE HD (Roche) and Lipofectamine 2000 (Invitrogen) were utilized respectively. For lentivirus production, polyethyleneimine (PEI) from EZ Trans, Liji ...